In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move rooted in a fundamental misunderstanding of vaccinology,” wrote Jake Scott, an ...

The Pfizer and Moderna COVID vaccines use mRNA technology to fight the virus. The same technology could lead to a long-desired vaccine for HIV/AIDS.